Emmaus Life Sciences (EMMA) Short Interest Ratio & Short Volume

Short interest is the volume of Emmaus Life Sciences shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 900 shares of EMMA short. Learn More on Emmaus Life Sciences' current short interest.

Emmaus Life Sciences saw a decline in short interest during the month of November. As of November 30th, there was short interest totaling 900 shares, a decline of 10.0% from the previous total of 1,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Emmaus Life Sciences: Aditxt, Inc. (1.27%), Biomerica, Inc. (8.50%), Aeterna Zentaris Inc. (0.18%), Bionomics Limited (2.27%), Alzamend Neuro, Inc. (3.11%), Avalon GloboCare Corp. (7.49%), Aptevo Therapeutics Inc. (7.60%), Creative Medical Technology Holdings, Inc. (1.75%), Lixte Biotechnology Holdings, Inc. (7.58%), Guardion Health Sciences, Inc. (1.76%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

Short selling EMMA is an investing strategy that aims to generate trading profit from Emmaus Life Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Emmaus Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EMMA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EMMA, twice per month. The most recent reporting period available is November, 30 2024.